Safety and efficacy of Vonoprazan-based triple therapy against infection: A single-center experience with 1118 patients
Main Authors: | Daisuke Fukuda, Yuko Akazawa, Fuminao Takeshima, Kazuhiko Nakao, Yutaka Fukuda |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-09-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X16654499 |
Similar Items
-
Vonoprazan-based therapy for eradication: experience and clinical evidence
by: Yuko Akazawa, et al.
Published: (2016-11-01) -
Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of infection
by: Mariko Hojo, et al.
Published: (2020-11-01) -
Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Clinical Trials
by: Qiu-Ju Lyu, et al.
Published: (2019-01-01) -
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
by: Hiroki Tanabe, et al.
Published: (2018-06-01) -
Polyglycolic Acid Felt Sealing Method for Prevention of Bleeding Related to Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents
by: Hiroko Fukuda, et al.
Published: (2016-01-01)